Frontiers in Cardiovascular Medicine

OCTOBER 24, 2024

There were no statistically significant differences in terms of stroke, paravalvular leak, mechanical ventilation time, blood transfusion requirements, pacemaker implantation, reexploration for bleeding, conversion, wound infection, or in-hospital stay. This was a retrospective, single-center observational study.

Aortic valve 52

Aortic valve Aortic Atrial Fibrillation Pacemaker 52

Heart BMJ

MAY 10, 2024

Objectives The use of cerebral embolic protection (CEP) during transcatheter aortic valve implantation (TAVI) has been studied in several randomised trials. We aimed to perform a systematic review and Bayesian meta-analysis of randomised CEP trials, focusing on a clinically relevant reduction in disabling stroke.

Aortic valve 52

Aortic valve Embolism Aortic Stroke 52

Becker's Hospital Review - Cardiology

JANUARY 5, 2024

A recent study found patients who undergo transcatheter aortic valve replacement have higher risk of stroke for up to two years after the procedure.

Aortic valve 69

Aortic valve TAVR Stroke Strokes 69

DAIC

MARCH 25, 2024

Fethi Benraouane , and Dr. Molham Aldeiri , have successfully performed the first series of transcarotid Transcatheter Aortic Valve Replacement (TAVR) procedures ever done in Southeast Houston. This novel approach potentially decreases the risk of stroke and vascular complications and makes more options available for patients.

TAVR 111

TAVR Open-Heart Surgery Aortic valve Aortic 111

Med Page Today

MARCH 30, 2025

(MedPage Today) -- CHICAGO -- Routine use of devices to prevent cerebral emboli during transcatheter aortic valve implantation (TAVI) did not prevent strokes, a large randomized trial showed. Incidence of stroke within 72 hours after TAVI or.

Aortic valve 52

Aortic valve Embolism Stroke Strokes 52

Circulation

NOVEMBER 11, 2024

Seven studies showed that TAVR patients had a similar 1-year stroke risk to SAVR patients (OR 0.92, 95% CI 0.64 Circulation, Volume 150, Issue Suppl_1 , Page A4142104-A4142104, November 12, 2024. All statistical analyses were conducted using Review Manager (Rev Man, Version 5.4; The Cochrane Collaboration, Copenhagen, Denmark).Results:After

Aortic valve 40

Aortic valve Aortic TAVR Stroke 40

DAIC

APRIL 30, 2024

SAVR after TAVR Surgical aortic valve replacement after prior TAVR is the fastest-growing cardiac surgery procedure in the U.S. The majority require explant of the TAVR device and SAVR, which significantly increases the risk of operative mortality and stroke. More than 5,500 multi-valve procedures were performed in the U.S.

TAVR 111

TAVR Aortic valve Tricuspid Coronary Artery Bypass Graft 111

Circulation: Cardiovascular Interventions

OCTOBER 17, 2023

BACKGROUND:Data concerning the outcomes of transcatheter aortic valve replacement in type 0 bicuspid aortic stenosis (AS) are scarce. Self-expanding transcatheter heart valves were used in the majority of patients (n=1160; 91.4%). Poverall=0.099) and all stroke (30 days: 1.0% Poverall=0.522; 1 year: 10% versus 2.3%

Aortic valve 40

Aortic valve Bicuspid/Mitral Aortic Tricuspid 40

European Journal of Heart Failure

JANUARY 31, 2024

ABSTRACT Patients with severe aortic stenosis (AS) may develop heart failure (HF), the presence of which has traditionally been deemed as a final stage in AS progression with poor outcomes. The use of transcatheter aortic valve replacement (TAVR) has become the preferred therapy for most patients with AS and concomitant HF.

Aortic valve 40

Aortic valve Heart Failure Aortic TAVR 40

Journal of the American Heart Association

MARCH 21, 2025

BackgroundWe aimed to reevaluate randomized controlled trial data on outcomes of cerebral embolic protection device use during transcatheter aortic valve implantation. Primary outcomes included all stroke, disabling stroke, and allcause mortality.

Aortic valve 40

Aortic valve Embolism Aortic Stroke 40

Nature Reviews - Cardiology

APRIL 9, 2025

Nature Reviews Cardiology, Published online: 10 April 2025; doi:10.1038/s41569-025-01156-9 Findings from the BHF PROTECT-TAVI trial indicate that the routine use of cerebral embolic protection devices during transcatheter aortic valve implantation does not decrease the incidence of stroke within 72 h after the intervention.

Embolism 46

Embolism Aortic valve Stroke Strokes 46

Journal of the American Heart Association

FEBRUARY 13, 2024

BackgroundAcute ischemic stroke complicates 2% to 3% of transcatheter aortic valve replacements (TAVRs). Fifty‐seven patients (1.7%) experienced a periprocedural stroke. The incidence of acute stroke was significantly higher among patients with a bovine arch compared with those with a nonbovine arch (3.6%

Aortic valve 40

Aortic valve Anatomy Aortic TAVR 40

DAIC

MARCH 31, 2025

Data shows, versus surgery, the Evolut transcatheter aortic valve replacement (TAVR) system delivers a numerically lower rate of all-cause mortality or disabling stroke at five years, strong valve performance and durable clinical outcomes. Evolut TAVR vs. 9.3%

TAVR 52

TAVR Stenosis Aortic Outcomes 52

The British Journal of Cardiology

FEBRUARY 20, 2024

Patients with bicuspid aortic valves (BAV) are predisposed to the development of aortic stenosis. We performed a pairwise meta-analysis, comparing the efficacy of transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR) in patients with BAV. to 4.58, p=0.04).

Aortic valve 40

Aortic valve Bicuspid/Mitral Aortic TAVR 40

Journal of the American Heart Association

JANUARY 19, 2024

BackgroundCerebral embolic protection devices (CEPD) capture embolic material in an attempt to reduce ischemic brain injury during transcatheter aortic valve replacement. Primary clinical outcome was all‐cause stroke. Secondary clinical outcomes were disabling stroke and all‐cause mortality.

Aortic valve 40

Aortic valve Embolism Aortic Stroke 40

American College of Cardiology

OCTOBER 29, 2024

The goal of the PROTECTED TAVR trial was to evaluate the efficacy of intraprocedural cerebral embolic protection (CEP) in reducing strokes among patients undergoing transfemoral TAVR for aortic stenosis.

Aortic valve 43

Aortic valve Aortic TAVR Stroke 43

Circulation

NOVEMBER 11, 2024

Introduction:Subclinical leaflet thrombosis is an increasingly recognized complication in patients undergoing transcatheter aortic valve replacement (TAVR). Patients with hypoattenuated leaflet thickening (HALT) and reduced leaflet motion (RELM) have a higher incidence of strokes and transient ischemic attacks.

Aortic valve 40

Aortic valve Thrombosis Aortic TAVR 40

Journal of the American Heart Association

FEBRUARY 14, 2025

BackgroundValveinvalve transcatheter aortic valve replacement (TAVR) is a recognized alternative for treating the structural valve deterioration of bioprosthetic valves. Recent guidelines and trials have expanded the indications for TAVR to include younger patients with structural valve deterioration.

Aortic valve 40

Aortic valve Aortic TAVR Outcomes 40

DAIC

JANUARY 29, 2024

Cardiac Surgery after Transcatheter Aortic Valve Replacement: Trends and Outcomes The researchers set out to document trends and outcomes in cardiac surgery following transcatheter aortic valve replacement (TAVR), a topic gaining importance as reports of subsequent cardiac operations and early TAVR explantations increase.

Research 111

Research TAVR Aortic valve Atrial Fibrillation 111

Open Heart

JANUARY 19, 2023

Objective Postprocedural ischaemic and bleeding risks after transcatheter aortic valve replacement (TAVR) remain a major concern. Ischaemic events were defined as myocardial infarction, stroke, transient ischaemic attack or peripheral embolism at 1 year.

Aortic valve 52

Aortic valve TAVR Aortic Myocardial Infarction 52

Journal of the American Heart Association

AUGUST 26, 2024

Journal of the American Heart Association, Ahead of Print.

Aortic valve 45

Aortic valve Aortic Stroke Strokes 45

The New England Journal of Medicine

MARCH 29, 2025

In a randomized trial, the routine use of cerebral embolic protection during TAVI did not reduce the incidence of stroke within 72 hours or before discharge from the hospital (if discharge occurred sooner).

Embolism 40

Embolism Aortic valve Aortic Hospital 40

DAIC

DECEMBER 18, 2023

It uses a three-star scale (3=better than expected, 2=as expected, 1=worse than expected) to rate institutions across five common cardiovascular procedures: coronary artery bypass grafting (CABG); aortic valve replacement (AVR); AVR and CABG; mitral valve replacement/repair (MVRR); and MVRR and CABG.

Cardiovascular Surgery 111

Cardiovascular Surgery Hospital Coronary Artery Bypass Graft Valve Replacement/Repair 111

Circulation

OCTOBER 25, 2023

Background:The optimal treatment in patients with severe aortic stenosis (AS) and small aortic annulus (SAA) remains to be determined. Participants were 151 patients with severe AS and SAA (mean diameter <23 mm) were randomized (1:1) to TAVR (n=77) vs SAVR (n=74), The primary outcome was impaired valve hemodynamics (i.e.

Aortic valve 40

Aortic valve Aortic TAVR Stenosis 40

Circulation

OCTOBER 23, 2023

Background: Atrial fibrillation (AF) is common in patients undergoing transcatheter aortic valve replacement (TAVR) and is associated with increased risk of bleeding and stroke. WATCHMAN patients received anticoagulation for 45 days followed by dual antiplatelet therapy until 6 months.

Aortic valve 40

Aortic valve Atrial Fibrillation TAVR Aortic 40

Circulation: Cardiovascular Interventions

OCTOBER 22, 2023

Background:Atherosclerotic cardiovascular disease (ASCVD) is highly prevalent in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (TAVR). Circulation: Cardiovascular Interventions, Ahead of Print. Primary outcome was all-cause mortality. 2VB-PVD, HR 1.12; 95% CI, 1.09-1.15,

Aortic valve 40

Aortic valve Aortic TAVR Outcomes 40

Coronary Artery Disease Journal

MAY 13, 2024

Objective To investigate the impact of prior coronary artery bypass grafting (CABG) and coronary lesion complexity on transcatheter aortic valve replacement (TAVR) outcomes for aortic stenosis.

Coronary Artery Bypass Graft 40

Coronary Artery Bypass Graft Aortic valve Aortic Stenosis 40

American College of Cardiology

AUGUST 14, 2024

What is the relationship between diffusion-weighted magnetic resonance imaging (DW-MRI) total lesion number (TLN), individual lesion volume (ILV), and total lesion volume (TLV) with clinical stroke outcomes after transcatheter aortic valve replacement (TAVR)?

TAVR 48

TAVR Aortic valve Aortic Stroke 48

Open Heart

SEPTEMBER 11, 2023

To clarify these contrasts, we examined the influence of HR, aortic compliance and stroke volume (SV) on RF in an ex vivo porcine model of severe AR. Methods Experiments were performed on porcine ascending aorta with aortic valves (n=12). Compliance was varied by inserting a Dacron graft close to the aortic valve.

Aortic 52

Aortic Aortic valve Stroke Strokes 52

Circulation

NOVEMBER 11, 2024

A fib is a well-established risk factor for ischemic strokes. In patients with nonvalvular A fib, the majority of embolic strokes are caused by thrombi development in the left atrial appendage. Systemic anticoagulation (AC) is effective in reducing stroke risk in patients with A fib. 5,661 underwent percutaneous closure.

Stroke 40

Stroke Strokes Aortic valve Document 40

DAIC

FEBRUARY 29, 2024

24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 Atrial Fibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Circulation

NOVEMBER 11, 2024

While intracardiac cardiac tumors and shunts are infrequent and typically asymptomatic, their existence can precipitate severe outcomes, including stroke, myocardial infarction and sudden death.Case Description:A 69-year-old female presented with left sided facial droop, slurred speech and left arm weakness.

Stroke 40

Stroke Strokes Aortic valve Myocardial Infarction 40

The American Journal of Cardiology

JULY 25, 2024

Publication date: Available online 25 July 2024 Source: The American Journal of Cardiology Author(s): Meng Li, Laurent Fauchier, Gregory Y.H.

Aortic valve 40

Aortic valve Atrial Fibrillation Aortic Stroke 40

HeartRhythm

APRIL 30, 2024

Thombus formation in the left atrial appendage (LAA) is a well known complication of atrial fibrillation (AF) and increases the risk of stroke. Cerebral protection devices (CPDs) are routinely used to capture and remove thrombus/debris during transcatheter aortic valve replacement procedures.

Aortic valve 40

Aortic valve Atrial Fibrillation Ablation Aortic 40

The American Journal of Cardiology

JULY 19, 2024

Publication date: Available online 18 July 2024 Source: The American Journal of Cardiology Author(s): Christian Hengstenberg, Martin Unverdorben, Helge Möllmann, Nicolas M. Van Mieghem, Holger Thiele, Peter Nordbeck, Tienush Rassaf, Raul Moreno, Roxana Mehran, James Jin, Irene Lang, Roland Veltkamp, George D.

Aortic valve 40

Aortic valve Risk Factors Atrial Fibrillation Aortic 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page A29-A29, February 1, 2025. Introduction:Early identification of the etiology of ischemic stroke is crucial for secondary prevention. Images were assessed for cardiac stroke sources. 126 scans (65.3%) were cases with imaging confirmed ischemic stroke.

Stroke 40

Stroke Strokes Aortic valve Cardiothoracic 40

Circulation: Cardiovascular Interventions

JUNE 4, 2024

Circulation: Cardiovascular Interventions, Ahead of Print.

Aortic valve 40

Aortic valve Cardiovascular Interventions Circulation Aortic 40